TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Genagon Therapeutics AB
Closing information (x1000 EUR)
| Closing information | 2022/12 | 2021/12 | 2020/12 |
| Turnover |
7
|
3
|
0 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
-883
|
-855
|
-520 |
| EBITDA |
-883
|
-855
|
-519 |
| Total assets |
511
|
1,138
|
247 |
| Current assets |
508
|
1,135
|
247 |
| Current liabilities |
61
|
98
|
64 |
| Equity capital |
449
|
1,040
|
-255 |
| - share capital |
18
|
18
|
12 |
| Employees (average) |
3
|
3
|
4 |
Financial ratios
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Solvency |
87.9%
|
91.4%
|
-103.2% |
| Turnover per employee |
2
|
1
|
0 |
| Profit as a percentage of turnover |
-12614.3%
|
-28500% | |
| Return on assets (ROA) |
-172.8%
|
-75.1%
|
-210.5% |
| Current ratio |
832.8%
|
1158.2%
|
385.9% |
| Return on equity (ROE) |
-196.7%
|
-82.2%
|
203.9% |
| Change turnover |
4
|
3
|
0 |
| Change turnover % | 111% | ||
| Chg. No. of employees |
0
|
-1
|
-1 |
| Chg. No. of employees % |
0%
|
-25%
|
-20% |
Total value of public sale
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.